Karyopharm Therapeutics (KPTI) Tops Q1 EPS by 7c; Offers FY23 Revenue Guidance
Go back to Karyopharm Therapeutics (KPTI) Tops Q1 EPS by 7c; Offers FY23 Revenue Guidance| KARYOPHARM THERAP (NASDAQ: KPTI) | Delayed: 1.88 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.88 | 52 Week High | $19.41 | |||
| Open | $1.88 | 52 Week Low | $4.83 | |||
| Day High | $1.88 | P/E | N/A | |||
| Day Low | $1.88 | EPS | $-2.74 | |||
| Volume | 1,043 | |||||
